Leaps by Bayer invests in paradigm-shifting advances in the life sciences, aiming to solve 10 huge challenges through scientific breakthroughs.
Joined November 2017
- Tweets 1,258
- Following 156
- Followers 30,859
- Likes 1,663
321 Photos and videos
Jun 11
We’re excited to announce our investment in @LeafAgriculture. Their farm data API standardizes diverse sources, helping teams accelerate product development & enable smarter decisions across agriculture: prnewswire.com/news-releases…
149
Jun 10
Gene therapy's biggest challenge? Delivery. We're excited to welcome SonoThera to our portfolio – using ultrasound-mediated delivery for safe, targeted genetic medicine. 👉businesswire.com/news/home/2…
2
3
355
What if the problem isn’t the drug, but reaching the tumor?
Jürgen Eckhardt explains in a new @Forbes op‑ed how precision radiation is changing what’s possible for hard‑to‑reach cancers.Read the full op‑ed: forbes.com/sites/juergeneckh…
284
Apr 29
Hope in science & anxiety about rapid change. Young people feel it most.
Our new report with @BCG & Ipsos UK builds on our global study, with qualitative interviews decoding attitudes toward AI in healthcare, CGT, cultivated meat & NGTs: go.bayer.com/Leapsbreakthrou…
1
1
232
Agricultural products aren't born overnight. From problem definition to discovery, testing, regulatory prep, and commercialization – it's a multi-stage journey. See what it takes to bring innovation to the field: ag-playbook.vercel.app/
228
Building successful AgTech requires more than breakthrough ideas. Long development timelines, rigorous field testing, and farmer partnerships shape the real path to market. Explore four consistent truths in the new Ag Playbook 2.0: ag-playbook.vercel.app/
219
Mar 26
Big congratulations to eGenesis on this outstanding recognition from Fast Company. Being named to the 2026 Most Innovative Companies list, including #1 in Biotech and #34 overall, is a powerful acknowledgment of the team’s work!
1
241
Mar 24
Early cancer–detection blood tests are generating attention. And just as many questions. Jürgen Eckhardt’s latest op‑ed in @Forbes breaks down what these tests can and can’t tell us today, why the science is promising, and where caution is still essential: forbes.com/sites/juergeneckh…
1
1
219
Mar 23
Two decades of AgTech evolution. From early experimentation to today's disciplined investment environment. Ag Playbook 2.0 shows how capital-market shifts have shaped the sector. Understanding these eras helps everyone make smarter decisions.
Read more: ag-playbook.vercel.app/
191
Mar 17
PJ Amini recently spoke with @AgFunder about the current state of agrifoodtech investing – from exits and IPO dynamics to AI-driven discovery & emerging genetic tools. Curious to explore PJ’s full perspective? Read the interview: agfundernews.com/leaps-by-ba…
193
Congrats on portfolio company NuCicer's partnership with Stricks Ag to deploy over 10,000 acres of high-protein chickpeas in the 2026 growing season, combining NuCicer's predictive breeding platform with Stricks Ag’s production network.
Read more: igrownews.com/nucicer-latest…
ALT NuCicer and Stricks Ag partnering to launch 10,000 acres of high-protein chickpeas. The logos for NuCicer and Bayer's leaps are also shown.
1
1
228
Researchers are advancing new ways to restore sight. Diseases like retinitis pigmentosa and dry AMD damage the retina’s light-sensing cells. Stem cell therapies, gene-based approaches, and implants are now advancing with early signs of improvement. 👉 forbes.com/sites/juergeneckh…
2
3
308
Feb 26
Where does CRISPR go next? Nobel Laureate Jennifer Doudna on the next phase: scalable treatments, earlier intervention, and impact in agriculture. Read the full interview: LINK
213
Feb 17
Gene editing is evolving, from correcting individual mutations to reimagining rare disease treatment at scale. Hear how David Liu's breakthrough advances in base and prime editing, delivery, and manufacturing are reshaping genetic medicine.
Read more: forbes.com/sites/juergeneckh…
2
6
727
We appreciate the trust of the @ReCodeTx team and the opportunity to support their work from an early stage. Working alongside Shehnaaz Suliman, our focus has been on providing support, network and perspective as the team advances its mission.
280
Jan 21
JPM 2026 offered a clear signal: momentum is returning to healthcare innovation. M&A is back, China's innovation accelerating, AI showing real proof, global markets changing, new modalities moving fast. Read Jürgen Eckhardt's take in @Forbes: forbes.com/sites/juergeneckh…
1
255
Jan 20
2025 marked 10 years of Leaps by Bayer: built on bold ideas and focused investment driving breakthroughs across health and agriculture.
188
Jan 14
Ten years of Leaps by Bayer backing breakthrough science across health and agriculture. A decade of impact turning ideas into real-world progress. 🚀 leaps.bayer.com/annual-revie…
246
Excited to share Bayer’s strategic collaboration and licensing agreement with Soufflé Therapeutics, following our initial investment. Together they aim to advance cell-specific siRNA therapy for dilated cardiomyopathy. Read more: businesswire.com/news/home/2…
1
330